| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/12/1999 | CA2239835A1 Human sdr2 cdna clone |
| 02/12/1999 | CA2239819A1 Ftsz |
| 02/11/1999 | WO1999006563A1 Novel bone mineralization proteins, dna, vectors, expression systems |
| 02/11/1999 | WO1999006558A1 Human longevity-assurance protein homologs |
| 02/11/1999 | WO1999006557A2 Mammalian cell membrane proteins; related reagents |
| 02/11/1999 | WO1999006540A2 Inhibitors of cell-cycle progression and uses related thereto |
| 02/11/1999 | WO1999006539A1 Zggbp1, novel peptides related to bipolar affective disorder type 1, sequences and uses thereof |
| 02/11/1999 | WO1999006437A1 Sulfonylated dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006436A1 Benzyl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006433A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006431A1 Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006409A1 Tricyclic vasopressin agonists |
| 02/11/1999 | WO1999006408A1 New 2,3-benzodiazepine derivatives |
| 02/11/1999 | WO1999006407A1 THERAPEUTICALLY ACTIVE 1,2,4-TRIAZOLO(4.,3-b) PYRIDAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS |
| 02/11/1999 | WO1999006403A1 Tricyclic vasopressin agonists |
| 02/11/1999 | WO1999006397A2 Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists |
| 02/11/1999 | WO1999006384A1 1-(n-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of the phenyl ring |
| 02/11/1999 | WO1999006383A1 Piperazine derivatives active on the lower urinary tract |
| 02/11/1999 | WO1999006382A1 1,4-disubstituted piperazines |
| 02/11/1999 | WO1999006375A1 Fused heterocyclic compounds and their use as kynurenine-3-hydroxylase inhibitors |
| 02/11/1999 | WO1999006374A1 Condensed pyrazole compounds |
| 02/11/1999 | WO1999006371A1 Heterocyclic derivatives which inhibit factor xa |
| 02/11/1999 | WO1999006367A1 Caspases and apoptosis |
| 02/11/1999 | WO1999006365A1 Mercaptoacylamino acids as metallo-beta-lactamase inhibitors |
| 02/11/1999 | WO1999006361A2 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases |
| 02/11/1999 | WO1999006354A1 Il-8 receptor antagonists |
| 02/11/1999 | WO1999006351A1 Process for converting propargylic amine-n-oxides to enaminones |
| 02/11/1999 | WO1999006340A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors |
| 02/11/1999 | WO1999006066A2 Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions |
| 02/11/1999 | WO1999006049A1 Integrin receptor antagonists |
| 02/11/1999 | WO1999006042A1 Caspases and apoptosis |
| 02/11/1999 | WO1999006041A1 SUBSTITUTED ALKANOHYDROXAMIC ACIDS AND METHOD OF REDUCING TNFα LEVELS |
| 02/11/1999 | WO1999006036A1 Use of selective rxr agonists to prevent surgical adhesions |
| 02/11/1999 | WO1999006033A2 An aqueous enteroclysis solution for the treatment of hepatic encephalopathy |
| 02/11/1999 | WO1999006025A1 Method and compositions for treating late phase allergic reactions and inflammatory diseases |
| 02/11/1999 | WO1998050397A3 Chimeric oligonucleotides and the use thereof |
| 02/11/1999 | WO1998050057A3 Agent for enhancing the heart force |
| 02/11/1999 | DE19728737C1 Verfahren zur Erkennung und Bestimmung von GnRH-Rezeptoren und die Verwendung von GnRH-Agonisten und GnRH-Antagonisten zur Behandlung eines Tumors ausgehend vom Hirn und/oder Nervensystem und/oder den Hirnhäuten A method for the detection and determination of GnRH receptors and the use of GnRH agonists and GnRH-antagonists for the treatment of a tumor originating in the brain and / or nervous system and / or the meninges |
| 02/11/1999 | CA2298766A1 Human longevity-assurance protein homologs |
| 02/11/1999 | CA2298682A1 Mercaptoacylamino acids as metallo-beta-lactamase inhibitors |
| 02/11/1999 | CA2298668A1 Caspases and apoptosis |
| 02/11/1999 | CA2298617A1 Acyclic metalloprotease inhibitors |
| 02/11/1999 | CA2298595A1 Process for converting propargylic amine-n-oxides to enaminones |
| 02/11/1999 | CA2298544A1 Integrin receptor antagonists |
| 02/11/1999 | CA2298115A1 Inhibitors of cell-cycle progression and uses related thereto |
| 02/11/1999 | CA2297894A1 Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists |
| 02/11/1999 | CA2297757A1 Caspases and apoptosis |
| 02/11/1999 | CA2297489A1 Novel bone mineralization proteins, dna, vectors, expression systems |
| 02/11/1999 | CA2297407A1 Tricyclic vasopressin agonists |
| 02/11/1999 | CA2297096A1 Condensed heterocyclic compounds |
| 02/11/1999 | CA2297095A1 1-(n-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of the phenyl ring |
| 02/11/1999 | CA2296606A1 Fused heterocyclic compounds and their use as kynurenine-3-hydroxylase inhibitors |
| 02/11/1999 | CA2296315A1 Therapeutically active 1,2,4-triazolo(4.,3-b) pyridazine derivatives as ligands for gaba receptors |
| 02/11/1999 | CA2295945A1 Heterocyclic derivatives which inhibit factor xa |
| 02/11/1999 | CA2295807A1 Use of selective rxr agonists to prevent surgical adhesions |
| 02/11/1999 | CA2295295A1 Substituted alkanohydroxamic acids and method of reducing tnf.alpha. levels |
| 02/11/1999 | CA2294064A1 Il-8 receptor antagonists |
| 02/11/1999 | CA2291473A1 Benzyl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | CA2290748A1 Sulfonylated dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | CA2290747A1 Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | CA2290746A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | CA2239221A1 Novel his5 |
| 02/10/1999 | EP0896061A2 RpoA gene from Staphylococcus aureus |
| 02/10/1999 | EP0896003A1 Peptides for reducing or inhibiting bone resorption, angiogenesis and restenosis |
| 02/10/1999 | EP0895988A1 Arylsulfonylamino hydroxamic acid derivatives |
| 02/10/1999 | EP0895783A2 Pharmaceutical composition comprising ifosfamide and carnitine |
| 02/10/1999 | EP0895478A1 Component b as cicatrizant |
| 02/10/1999 | EP0895475A1 Vitronectin receptor antagonists |
| 02/10/1999 | EP0766699B1 Esterified polyanionic cyclodextrins as smooth muscle cell proliferation inhibitors |
| 02/10/1999 | EP0710239B1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 02/10/1999 | EP0659174B1 Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants |
| 02/10/1999 | CN1207769A Tissue-specific and target RNA-specific ribozymes |
| 02/10/1999 | CN1207743A Inhibitors of interleukin-1 'beta' converting enzyme |
| 02/10/1999 | CN1207734A Metalloproteinase inhibitors, pharmaceutical compositions contg. them and their pharmaceutical uses, and methods and intermediates useful for their preparation |
| 02/10/1999 | CN1207731A 3-pyrazolecarboxamide derivs. having cannabinoid receptor affinity |
| 02/10/1999 | CN1207728A Salt of quinoline derivs. as NK3 antagonists |
| 02/10/1999 | CN1207727A Substd. aryl or heteroarylamides having retinoid-like biological activity |
| 02/10/1999 | CN1207682A Method and material for hair therapy |
| 02/10/1999 | CN1207679A Use of cholinesterase inhibitors in treatment of xerostomia |
| 02/10/1999 | CN1207675A Sublingual and buccal administration of selegiline |
| 02/10/1999 | CN1207384A Amino compounds of 6,7,8,9-tetrahydro-cyclopenta[a]naphthalene and of 2,3-dihydro-cyclopenta[e]indene |
| 02/10/1999 | CN1207309A Process for preparation of Rhus verniciflus extract and anti-cancer composition containing same |
| 02/10/1999 | CN1207308A Juice for tonifying kidney and nourishing stomach |
| 02/10/1999 | CN1207305A Multifunctional body-building hand knitting yarn and preparing process |
| 02/10/1999 | CN1042031C Quaternary nitrogen-contg. phosphonate compounds, pharmaceutical compositions and use thereof |
| 02/10/1999 | CN1042026C 25 carboxylic deriv. of vitamin D series, its preparing method, middle products in production of same and medicine contg. same and pharmaceutical use of same in treatment |
| 02/09/1999 | US5869685 Serotonin reuptake inhibitors |
| 02/09/1999 | US5869663 Intermediates for neurokinin receptor antagonists |
| 02/09/1999 | US5869638 Bone-related cadherin-like protein and process for its production |
| 02/09/1999 | US5869633 Thrombin receptor homolog polynucleotide |
| 02/09/1999 | US5869603 Amino acid sequences of synthetic peptides binding to neutralizing antibodies against recombinant interferon-beta; for detection and inhibition of antibodies in patients |
| 02/09/1999 | US5869534 Administering aminoguanidine and analogs thereof to reduce lipid oxidation and inhibit an increase in serum low density lipoproteins to prevent disease states characterized by the presence of advanced glycosylation endproducts |
| 02/09/1999 | US5869531 No undesireable salidiuretic properties; treating ischemia induced disorders |
| 02/09/1999 | US5869516 4-(arylaminomethylene)-2,4-dihydro-3-pyrazolones |
| 02/09/1999 | US5869509 Treat disorders responsive to openers of the large conductance calcium-activated potassium channels |
| 02/09/1999 | US5869502 Treating depression, obsessive compulsive disorder, stuttering, trichotillomania |
| 02/09/1999 | US5869496 Treating asthma, emesis |
| 02/09/1999 | US5869492 Condensed thiazole derivatives, having 5-HT receptor affinity |
| 02/09/1999 | US5869486 Fused pyrimidines and pyriazines as pharmaceutical compounds |
| 02/09/1999 | US5869485 Treatment of diseases which respond to inhibition of the activity of the protein tyrosine kinase |